IMM — ImmuPharma Cashflow Statement
0.000.00%
Last trade - 00:00- £10.12m
- £9.91m
Annual cashflow statement for ImmuPharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.28 | -5.59 | -6.59 | -3.03 | -3.06 |
| Depreciation | |||||
| Non-Cash Items | 1.46 | 1.43 | 0.619 | 0.115 | 0.235 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.511 | 0.656 | 1.02 | 0.449 | 1.43 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.22 | -3.33 | -4.83 | -2.35 | -1.36 |
| Capital Expenditures | -0.107 | -0.36 | -0.051 | -0.106 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.006 | -0.209 | 0.001 | 0.029 | 0.189 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.101 | -0.569 | -0.05 | -0.077 | 0.189 |
| Financing Cash Flow Items | -2.24 | -0.945 | -2.12 | -0.803 | -0.759 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.326 | 8.37 | 0.702 | 1.55 | 0.722 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.55 | 4.5 | -4.21 | -0.982 | -0.459 |